Share on LinkedInShare on LinkedIn

ARTICLE · 02 APRIL 2019

SPC MW – A New Privilege For Generics Producers?

JWP Patent & Trademark Attorneys sp.k.
Explore more from JWP Patent & Trademark Attorneys sp.k.

The pharmaceutical industry is divided into two categories of manufacturers: original drug companies and generics companies.

European UnionIntellectual Property

The pharmaceutical industry is divided into two categories of manufacturers: original drug companies and generics companies.

Original drug manufacturers are usually those who first look for new molecular targets that could be the target for completely new drugs and then, over the course of laborious and expensive research and development, create new preparations and formulations in order to verify the efficacy of the product in clinical trials, and finally register the new drug.

On the other hand, generics pharmaceutical manufacturers shorten the research and development process to include only a stage for developing alternative formulations or recreating the composition of original drugs based on the results of the research conducted by the original manufacturer.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from